Codiak BioSciences (CDAK) director Haddock acquired 8,750 shares
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Jason Haddock (director at Codiak BioSciences Inc., CDAK) reported that they acquired 8,750 shares on Feb 16, 2023. After these transactions the filing shows 8,750 shares held directly.
- Reporting person
- Haddock Jason
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Feb 16, 2023 | Exercise or conversion of a derivative (M) | Common Stock1 | +8,750 | - | - | 8,750 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Feb 16, 2023 | Exercise or conversion of a derivative (M) | Restricted Stock UnitsOn 8,750 Common Stock2, 3 | -8,750 | - | - | 0 direct |
Holdings before and after
- Common Stock: 0 to 8,750 direct
- Restricted Stock Units: 8,750 to 0 direct
Footnotes from the filing
- 1. Restricted stock units ( RSUs ) convert into common stock on a one-for-one basis.
- 2. Each RSU represents a contingent right to receive one share of common stock.
- 3. On February 16, 2022, the reporting person was granted 8,750 RSUs, which vested in full on February 16, 2023.
Transaction codes in this filing
- Exercise or conversion of a derivative:
- Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
FAQ
What did Haddock report in this CDAK Form 4?
Jason Haddock (director at Codiak BioSciences Inc., CDAK) reported that they acquired 8,750 shares on Feb 16, 2023. After these transactions the filing shows 8,750 shares held directly.
How many CDAK shares does Haddock hold after this filing?
The filing shows 8,750 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code M mean on an SEC Form 4?
Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
Historical context for CDAK
Earlier insider filings at CDAK
- Feb 21, 2023SEC Form 4: Sathyanarayanan Sriram converted options into 14,700 shares and sold $6,476 worth of shares (4,690 units at $1.38), increasing direct ownership by 571% to 11,762 units (withholding obligation)
- Feb 21, 2023SEC Form 4: Barna Nicole converted options into 6,300 shares and sold $2,932 worth of shares (2,258 units at $1.30), increasing direct ownership by 50% to 12,154 units to cover taxes
- Feb 21, 2023SEC Form 4: Gillis Steven converted options into 8,750 shares
- Feb 21, 2023SEC Form 4: Cooney Charles L converted options into 8,750 shares
- Feb 21, 2023SEC Form 4: Melas Kyriazi Theo converted options into 8,750 shares, increasing direct ownership by 133% to 15,350 units
Quantisnow market dataNASDAQ
CDAK
Codiak BioSciences Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- Listed since
- 2020
Get push alerts for CDAK
Full CDAK profile on Quantisnow Follow CDAK and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time